BLPH

Bellerophon Therapeutics, Inc.
BLPH

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

BLPH was delisted on the 13th of October, 2023.

Back to rankings

41 hedge funds and large institutions have $38.9M invested in Bellerophon Therapeutics, Inc. in 2020 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 14 increasing their positions, 8 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

more funds holding in top 10

Funds holding in top 10: →

18% less capital invested

Capital invested by funds: $47.3M → $38.9M (-$8.4M)

Holders
41
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$1.1M
2
+$347K
3
+$292K
4
GCP
GSA Capital Partners
United Kingdom
+$286K
5
State Street
State Street
Massachusetts
+$272K

Top Sellers

1
-$1.24M
2
-$507K
3
-$495K
4
Nuveen Asset Management
Nuveen Asset Management
Illinois
-$271K
5
ECM
ExodusPoint Capital Management
New York
-$207K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$27K
27
$25K
28
$23K
29
$22K
30
$12K
31
$10K
32
$9K
33
$7K
34
$6K
35
$3K
36
$3K
37
$2K
38
$2K
39
$1K
40
$1K
41
$682
42
–
43
–
44
–
45
–
46
–
47
–
48
–
1
2